CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study

  • Katharina Kriegsmann (Shared first author)
  • Gigi Nu Hoang Quy Ton (Shared first author)
  • Mohamed H S Awwad (Shared first author)
  • Axel Benner
  • Uta Bertsch
  • Britta Besemer
  • Mathias Hänel
  • Roland Fenk
  • Markus Munder
  • Jan Dürig
  • Igor W Blau
  • Stefanie Huhn
  • Dirk Hose
  • Anna Jauch
  • Christoph Mann
  • Niels Weinhold
  • Christof Scheid
  • Roland Schroers
  • Ivana von Metzler
  • Aneta Schieferdecker
  • Jörg Thomalla
  • Peter Reimer
  • Rolf Mahlberg
  • Ullrich Graeven
  • Stephan Kremers
  • Uwe M Martens
  • Christian Kunz
  • Manfred Hensel
  • Andrea Seidel-Glätzer
  • Katja C Weisel
  • Hans J Salwender
  • Carsten Müller-Tidow
  • Marc S Raab
  • Hartmut Goldschmidt (Shared last author)
  • Elias K Mai (Shared last author)
  • Michael Hundemer (Shared last author)

Related Research units

Bibliographical data

Original languageEnglish
ISSN0887-6924
DOIs
Publication statusPublished - 07.2024
PubMed 38830959